Walleye Trading
WINT

Walleye Trading’s Windtree Therapeutics Inc WINT Stock Holding History

Walleye Trading’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,200
Closed -$9K – 6027
2016
Q1 		$9K Buy
+5,200
New +$11.2K ﹤0.01% 4792

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's WINT Position: Q2 2016 in Review

Walleye Trading sold out of Windtree Therapeutics Inc (WINT) in Q2 2016, closing a stake of 5,200 shares — an estimated $9K sold.

Walleye Trading first reported a position in WINT in Q1 2016 and held it in 1 quarter. The position peaked at $9K in Q1 2016. 33 funds tracked by Wall St. Rank hold WINT as of Q2 2016.

  • Walleye Trading reported no remaining Windtree Therapeutics Inc position as of Q2 2016 after selling out during the quarter.
  • Walleye Trading sold 5,200 Windtree Therapeutics Inc shares in Q2 2016, an estimated $9K.
  • Walleye Trading first reported a position in Windtree Therapeutics Inc in Q1 2016 and held it in 1 quarter.
  • Walleye Trading's Windtree Therapeutics Inc position peaked at $9K in Q1 2016.
  • 33 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2016.

Based on Walleye Trading's 13F filing for Q2 2016, filed 15 Aug 2016.